• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善III-B期宫颈癌预后的肿瘤及治疗因素

Tumor and treatment factors improving outcome in stage III-B cervix cancer.

作者信息

Lanciano R M, Martz K, Coia L R, Hanks G E

机构信息

Department of Radiation Oncology, Fox Chase Cancer Center-University of Pennsylvania, Philadelphia 19111.

出版信息

Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):95-100. doi: 10.1016/0360-3016(91)90143-r.

DOI:10.1016/0360-3016(91)90143-r
PMID:1993635
Abstract

This report reviews 271 patients with Stage III-B squamous cell cancer of the uterine cervix from three national surveys conducted by the Patterns of Care Study. A progressive increase in local control and survival is seen among the three surveys which parallels a progressive increase in paracentral (point A) dose and use of intracavitary treatment. Multivariate analysis reveals extent of pelvic disease (unilateral sidewall vs. bilateral sidewall vs. lower 1/3 vagina) and use of intracavitary treatment to be the only significant tumor and treatment factors associated with local control and survival. With aggressive radiotherapy, local control rates exceeding 65% and survival of 50% at 4 years can be anticipated at the expense of a small increase in complications.

摘要

本报告回顾了由治疗模式研究进行的三项全国性调查中的271例III - B期子宫颈鳞状细胞癌患者。在三项调查中,局部控制率和生存率逐步提高,这与宫旁(A点)剂量的逐步增加以及腔内治疗的使用情况相平行。多变量分析显示,盆腔疾病范围(单侧侧壁 vs. 双侧侧壁 vs. 阴道下1/3)和腔内治疗的使用是与局部控制和生存相关的仅有的重要肿瘤和治疗因素。通过积极的放射治疗,可以预期局部控制率超过65%,4年生存率为50%,但并发症会略有增加。

相似文献

1
Tumor and treatment factors improving outcome in stage III-B cervix cancer.改善III-B期宫颈癌预后的肿瘤及治疗因素
Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):95-100. doi: 10.1016/0360-3016(91)90143-r.
2
Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.子宫颈鳞状细胞癌中与改善预后相关的预处理和治疗因素:1973年和1978年护理模式研究的最终报告
Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):667-76. doi: 10.1016/0360-3016(91)90007-q.
3
The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey.
Cancer. 1990 Dec 15;66(12):2451-6. doi: 10.1002/1097-0142(19901215)66:12<2451::aid-cncr2820661202>3.0.co;2-5.
4
Comparison of 1 vs 2 or more intracavitary brachytherapy applications in the management of carcinoma of the cervix, with irradiation alone.在宫颈癌治疗中,将腔内近距离放射治疗单次应用与两次或更多次应用进行比较,并与单纯放疗对比。
Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):81-5. doi: 10.1016/0360-3016(91)90141-p.
5
Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978.
Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):87-93. doi: 10.1016/0360-3016(91)90142-q.
6
Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.子宫颈癌。I. 总治疗时间延长及近距离放疗时机对放射治疗结局的影响。
Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1275-88. doi: 10.1016/0360-3016(95)00220-S.
7
Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.中剂量率腔内近距离放疗治疗宫颈癌的疗效:与低剂量率腔内近距离放疗的比较。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):137-45. doi: 10.1016/j.ijrobp.2011.10.066. Epub 2012 Jan 26.
8
Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.国际妇产科联盟(FIGO)IB期子宫颈癌的分割外照射和高剂量率腔内近距离放射治疗的剂量优化
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1338-44. doi: 10.1016/s0360-3016(01)02821-8.
9
[Radiation therapy for squamous cell carcinoma of uterine cervix using high dose rate intracavitary irradiation].[高剂量率腔内照射用于子宫颈鳞状细胞癌的放射治疗]
Nihon Igaku Hoshasen Gakkai Zasshi. 1994 Oct 25;54(12):1155-64.
10
Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.子宫颈癌的肿瘤大小、放射剂量及长期预后
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):307-17. doi: 10.1016/s0360-3016(98)00067-4.

引用本文的文献

1
Proof-of-concept of real-time electromagnetic guidance for gynecologic interstitial catheters in high dose rate brachytherapy.高剂量率近距离放射治疗中妇科组织间插植导管实时电磁导航的概念验证
Phys Imaging Radiat Oncol. 2024 Oct 24;32:100661. doi: 10.1016/j.phro.2024.100661. eCollection 2024 Oct.
2
A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.局部晚期宫颈癌临床结局的对比研究:外照射放疗(EBRT)与序贯高剂量率腔内近距离放疗(HDRICBT)联合或不联合当日 ICBT 插入时顺铂同步治疗——印度一家三级护理中心的随机对照试验。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1333-1338. doi: 10.31557/APJCP.2024.25.4.1333.
3
External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.外照射放疗与高剂量率(HDR)腔内近距离放疗联合与外照射放疗后序贯 HDR 腔内近距离放疗治疗局部晚期宫颈癌的随机对照研究。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3441-3445. doi: 10.31557/APJCP.2023.24.10.3441.
4
Evaluation of doses to pelvic lymph node regions from image-guided high-dose-rate interstitial brachytherapy for carcinoma of the uterine cervix.子宫颈癌图像引导高剂量率组织间近距离治疗中盆腔淋巴结区域剂量评估
J Contemp Brachytherapy. 2023 Aug;15(4):261-268. doi: 10.5114/jcb.2023.130992. Epub 2023 Aug 31.
5
Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.2D 近距离放疗与 3D 图像引导自适应近距离放疗治疗局部晚期宫颈癌的安全性和疗效:单中心回顾性研究。
Curr Oncol. 2023 May 13;30(5):4966-4978. doi: 10.3390/curroncol30050375.
6
Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.接受放化疗后辅助近距离放疗的美国癌症联合委员会(AJCC)分期为T1和T2期宫颈癌患者的局部控制和无进展生存的预后因素。
J Contemp Brachytherapy. 2023 Feb;15(1):27-36. doi: 10.5114/jcb.2023.124936. Epub 2023 Feb 9.
7
Reporting of Inter Fraction Dose Variations of Organs at Risk in Computed Tomography-Guided High Dose Rate Intracavitary Brachytherapy in Carcinoma Cervix.宫颈癌计算机断层扫描引导下高剂量率腔内近距离治疗中危及器官分次间剂量变化的报告
J Med Phys. 2022 Oct-Dec;47(4):394-397. doi: 10.4103/jmp.jmp_91_22. Epub 2023 Jan 10.
8
The effect of dose-painted intensity-modulated radiotherapy combined with chemotherapy for stage IIIB cervical cancer.剂量勾画调强放疗联合化疗治疗IIIB期宫颈癌的疗效
Am J Transl Res. 2021 Apr 15;13(4):2813-2821. eCollection 2021.
9
Quality Assurance in Modern Gynecological HDR-Brachytherapy (Interventional Radiotherapy): Clinical Considerations and Comments.现代妇科高剂量率近距离放疗(介入放射治疗)中的质量保证:临床考量与评论
Cancers (Basel). 2021 Feb 22;13(4):912. doi: 10.3390/cancers13040912.
10
Comparative analysis of image-guided adaptive interstitial brachytherapy and intensity-modulated arc therapy versus conventional treatment techniques in cervical cancer using biological dose summation.使用生物剂量求和法对宫颈癌图像引导自适应组织间近距离放疗和调强弧形放疗与传统治疗技术进行对比分析。
J Contemp Brachytherapy. 2019 Feb;11(1):69-75. doi: 10.5114/jcb.2019.82999. Epub 2019 Feb 28.